[Ip-health] SAVE THE DATE: Progress and challenges: Scaling up drug-resistant TB treatment -- 28 October, TB Conf. LILLE

Katy Athersuch katy.athersuch at googlemail.com
Wed Jul 27 09:36:27 PDT 2011

*Satellite Event at the TB Union Conference:
Progress and challenges: Scaling up drug-resistant TB treatment
28 October 2011 -- Lille, France

A recent evaluation carried out by Medecins Sans Frontieres, Partners in
Health and Treatment Action Group concluded that current global structures
to assist scale up of DR-TB treatment are not adequate to support the
growing caseload in high-burden, resource-limited countries (

With the GLC and GDF currently in a reform process, and the GLI setting up
systems to better document its progress, the time is right to assess the
role of the GLC, GLI, and GDF in the scale up of DR-TB treatment so far, and
consider ways in which they can improve in their assistance to countries in
overcoming the many challenges ahead when scaling up DR-TB treatment.

This satellite will bring together a range of stakeholders to debate key
issues for the immediate and longer term, including:
- How should the global initiatives contribute to future national MDR-TB
- What data is required to enable better evaluation of the control of
- How can global initiatives contribute to overcoming the challenges to
accessing quality diagnostics and drug supply?
- What role can civil society groups have in providing feedback and
evaluation on the performance of the global initiatives at the country

A more detailed programme with speakers will be forwarded closer to the


Date: Friday 28th of October 2011
Location: Crown Plaza, 335 boulevard de Leeds 59777 Lille, FRANCE
Time: 5.30 – 9.30pm
Organizers: MSF Campaign for Access to Essential Medicines, Treatment Action
Group, Partners In Health

Please feel free to forward this to other interested parties.



Dr Grania Brigden
TB advisor
Médecins Sans Frontières
Campaign for Access to Essential Medicines
Rue de Lausanne 82
1211 Geneva, Switzerland
Tel: + 41(0) 22 849 87 56

More information about the Ip-health mailing list